Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
about
Nutritional support for liver diseaseNutrition and Hepatocellular CancerLiver Cirrhosis: Evaluation, Nutritional Status, and Prognosis.Nutrition and metabolism in hepatocellular carcinomaBranched-chain amino acids in metabolic signalling and insulin resistanceOral branched-chain amino acid granules improve structure and function of human serum albumin in cirrhotic patientsEffects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study.Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease.Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma.Effects of branched-chain amino acid granules on serum albumin level and prognosis are dependent on treatment adherence in patients with liver cirrhosis.Branched-chain amino acids in liver diseases.Molecular targeted therapy for hepatocellular carcinoma: bench to bedside.Early administration of branched-chain amino acid granulesClinical significance of therapy using branched-chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma.Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.The impact of diet and nutrition in the prevention and progression of hepatocellular carcinoma.Effect of treatment with branched-chain amino acids during sorafenib therapy for unresectable hepatocellular carcinoma.Protective effects of branched-chain amino acids on hepatic ischemia-reperfusion-induced liver injury in rats: a direct attenuation of Kupffer cell activation.
P2860
Q24197811-A983E757-51A6-4B89-9E78-615347152350Q26741102-8A8C6FDE-281B-46AD-AEEE-CB1A9B210D79Q26780309-9400916A-6A07-41E1-8599-D2CE7E2FA6E7Q26862862-298A417B-C2C7-4CE1-A17E-CC053F916DAAQ28249276-DDAC773F-F7FA-4868-97AE-88ADECE61BB7Q33705346-35CE1A5D-74F0-4D7E-A073-A26A295671F5Q33817993-EC64C57A-F7B9-4CB4-AB70-755BD77C73EEQ35085125-FF6F4EEA-3A94-48EB-8DA7-316413E9ED55Q35872118-02A2C30D-2338-4A8F-9707-E7CB93DBCEA5Q37001748-217F2B17-6568-4D85-9383-2927984B99D6Q37334109-5AD207A1-2558-4A61-B7BD-B0F2BB85B8F7Q37914624-4FF49974-944A-47AB-A6D8-3C4E08CFA1F0Q38042596-70F9307C-F92E-4ED8-8B73-DA13783F66D7Q38118780-14F14539-7AE8-4C26-ADB1-34FFC4D7904DQ38128967-A087CB08-DF8B-40A3-A40D-DEEC92DF607EQ38165918-C855A29E-CB4E-4761-8EA3-7DF5F1F1FF60Q38193582-6CE965BA-431E-4ECC-97FD-F79CA83710FBQ50492074-05F2C708-D329-427D-87FE-FE8F075073EFQ53127077-4615BA64-CF75-41A4-B5EC-E0F5522106C0
P2860
Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Oral branched-chain amino acid ...... patients with liver cirrhosis.
@en
Oral branched-chain amino acid ...... patients with liver cirrhosis.
@nl
type
label
Oral branched-chain amino acid ...... patients with liver cirrhosis.
@en
Oral branched-chain amino acid ...... patients with liver cirrhosis.
@nl
prefLabel
Oral branched-chain amino acid ...... patients with liver cirrhosis.
@en
Oral branched-chain amino acid ...... patients with liver cirrhosis.
@nl
P2093
P2860
P356
P1433
P1476
Oral branched-chain amino acid ...... patients with liver cirrhosis.
@en
P2093
Emi Ishikawa
Hobyung Chung
Kazuomi Ueshima
Masahiro Takita
Norihisa Yada
Satoru Hagiwara
Satoshi Kitai
Sosuke Hayaishi
Taisuke Ueda
Tatsuo Inoue
P2860
P304
P356
10.1159/000327571
P577
2011-08-09T00:00:00Z